US biotech Atossa Therapeutics (Nasdaq: ATOS) has entered into a research collaboration with China-backed Nona Biosciences, ...

Pain is good. Or finding non-opioid ways to manage it is good, if Latigo Biotherapeutics’ $150 million March fundraise is ...

US clinical-stage biotech Imbria Pharmaceuticals, which is focused on cardiometabolic diseases with high unmet need, says it ...

Danish pharma major Novo Nordisk has announced an investment of $1.1 billion to expand its production facility in Brazil’s ...

Menarini Biotech, a group company of Italy’s Menarini, has entered into a strategic collaboration with ERBC, a leading ...

US biotech ImmunityBio (Nasdaq: IBRX) has secured $75 million through a direct offering with a single institutional investor, ...

Solu Therapeutics, a US biotech developing therapies to eliminate disease-driving cells in cancer, immunology and other ...

California-based clinical-stage biotech Tempest Therapeutics (Nasdaq: TPST) has announced that the company plans to explore a ...

The All-Russian Union of Patients (VSP) has called on Russia’s Deputy Prime Minister, Tatyana Golikova, to expand the list of ...

The first comprehensive analysis of clinical trials in the UK has found the country remains a global leader in medical ...

Chinese biotech RemeGen (SHA: 688331) has reported positive late-stage clinical trial data for its dual-target fusion protein ...

South Korea’s Samsung Bioepis presented data, including the budget impact analysis on ustekinumab biosimilars’ cost savings ...